Notice of Intent to Sole Source – Cyvek NOI-CC-25-007627
Summary
AI-generated · Aug 28, 2025Procurement of Simple Plex cartridge kits, consumables used for protein determination in serum or patient samples, compatible with the Ella Instrument. The Ella platform measures protein biomarkers, and to maintain continuity with previously generated data, the same technology and reagents are required. Simple Plex cartridges are the compatible reagents sold by the Ella Instrument’s manufacturer, the sole company that provides compatible cartridges for this instrument.
This action is a sole-source intent under FAR Part 13 Simplified Acquisition Procedures (Subpart 13.106-1(b)(1)); for purchases not exceeding the simplified acquisition threshold, only one source may be reasonably available. No solicitation will be issued. Interested parties may identify their capabilities in response to this posting. Comments may be submitted to the NIH Clinical Center, Office of Purchasing and Contracts.
This is a notice of intent, not a request for a quotation. A solicitation document will not be issued and quotations will not be requested. This procurement is for Simple Plex cartridges kits. These are consumables for protein determination on serum/sample of research patients that are compatible with the Ella Instrument. The Ella instrument is used for determination of protein biomarkers in patient samples. To continue using the same assays for comparing previously generated data, the same technology is required. Simple Plex cartridges are the compatible reagents that can be used in the Ella Instrument. The vendor is the manufacturer of ELLA Instrument and the only company that sells reagents compatible with the Instrument. This acquisition is being conducted using policies unique to the Federal Acquisition Regulation (FAR) Part 13 Simplified Acquisition Procedures, Subpart 13.106-1(b)(1), For purchases not exceeding the simplified acquisition threshold (SAT), contracting officers may solicit from one source if the contracting officer determines that the circumstance of the contract action deem only one source reasonably available. Contracts awarded using FAR Part 13-Simplified Acquisition Procedures are exempt from the requirements of FAR Part 6-CompetitionRequirements. Interested parties may identify their interest and capabilities in response to this posting. The determination by the Government not to compete the proposed requirement based upon responses to this notice is solely within the discretion of the Government. Comments to this announcement, referencing this posting number, may be submitted to the NIH, Clinical Center, Office of Purchasing and Contracts, prior to the closing date specified in this announcement, to the attention of Ryssa Nix, Contract Specialist via email to Ryssa.nix@nih.gov by close date.
From Special Notice posted on Aug 27, 2025Notice history
1Details
Award Information
Not yet awarded
Contacts
Agency
Place of Performance
USA